Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 percent of all prescriptions filled in the United States yet accounted for only twelve percent of prescription drug spending.
That massive divergence in volume versus cost underlines the simple fact that the price competition engendered by generic drugs dramatically drives down prices and delivers savings to patients, employers, and taxpayers.
Read Full Article »
